Enhancement of osteoblast biocompatibility on titanium surface with Terrein treatment

Cell Biochemistry and Function

Volumn 28, Issue 8, 2010, Pages 678-685

  Lee, Young Hee ^a   Lee, Nan Hee ^a   Bhattarai, Govinda ^a   Oh, Young Taek ^a   Yu, Mi Kyung ^a   Yoo, Ick Dong ^b   Jhee, Eun Chung ^a   Yi, Ho Keun ^a  

^a Chonbuk National University   (South Korea)

^b Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

Author keywords

Antioxidant; Biocompatibility; Implant; Osseointegration; Osteolysis; Terrein; Titanium

Indexed keywords

[5 (2,4 DICHLOROBENZOYL) 2 HYDROXYPHENYL]ACETIC ACID; COPPER ZINC SUPEROXIDE DISMUTASE; FOCAL ADHESION KINASE; INDUCIBLE NITRIC OXIDE SYNTHASE; MANGANESE SUPEROXIDE DISMUTASE; MITOGEN ACTIVATED PROTEIN KINASE; OSTEOCLAST DIFFERENTIATION FACTOR; REACTIVE OXYGEN METABOLITE; TERREIN; TITANIUM;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; BIOCOMPATIBILITY; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL GROWTH; CONCENTRATION RESPONSE; CONTROLLED STUDY; CULTURE MEDIUM; DOWN REGULATION; ENZYME ACTIVITY; IMPLANT; INFLAMMATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OXIDATIVE STRESS; PENICILLIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; SURFACE PROPERTY; UPREGULATION;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLOPENTANES; MATERIALS TESTING; MICE; OSTEOBLASTS; OSTEOCLASTS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TITANIUM;

EID: 78649463147     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1708     Document Type: Article

References (38)

1. Chiapasco M, Gatti C. Implant-retained mandibular overdentures with immediate loading: a 3- to 8-year prospective study on 328 implants. Clin Implant Dent Relat Res 2003; 5: 29-38.
2. Brånemark PI. Osseointegration and its experimental studies. J Prosthet Dent 1983; 50: 399-410.
3. Kim TI, Jang JH, Kim HW, et al. Biomimetic approach to dental implants. Curr Pharm Des 2008; 14: 2201-2211.
4. Avila G, Misch K, Galindo-Moreno P, et al. Implant surface treatment using biomimetic agents. Implant Dent 2009; 18: 7-26.
5. Holt G, Murnaghan C, Reilly J, et al. The biology of aseptic osteolysis. Clin Orthop Relat Res 2007; 460: 240-252.
6. Mavrogenis AF, Dimitriou R, Parvizi J, et al. Biology of implant osseointegration. J Musculoskelet Nuronal Interac 2009; 9: 61-71.
7. Basu S, Michaëlsson K, Olofsson H, et al. Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 2001; 288: 275-279. DOI: 10.1006/bbrc.2001.5747
8. Callahan BC, Lisecki EJ, Banks RE, et al. The effect of warfarin on the attachment of bone to hydroxyapatite-coated and uncoated porous implants. J Bone Joint Surg Am 1995; 77: 225-230.
9. Dahners LE, Mullis BH. Effect of nonsteroidal anti-inflammatory drugs on bone formation and soft-tissue healing. J Am Acad Orthop Surg 2004; 12: 139-143.
10. Wattel A, Kamel S, Prouillet C, et al. Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NF kappa B and AP-1. J Cell Biochem 2004; 92: 285-295. DOI: 10.1002/jcb.20071
11. Kim HJ, Chang EJ, Kim HM, et al. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha. Free Radic Biol Med 2006; 40: 1483-1493. DOI: 10.1016/j.freeradbiomed.2005.10.066
12. Zaidi M. Skeletal remodeling in health and disease. Nat Med 2007; 13: 791-801. DOI: 10.1038/nm1593
13. Hsu H, Lacey DL, Dunstan CR, et al. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc Natl Acad Sci USA 1999; 96: 3540-3545.
14. Hughes AE, Ralston SH, Marken J, et al. Mutations in TNFRSF11A, affecting the signal peptide of RANK, cause familial expansile osteolysis. Nat Genet 2000; 24: 45-48. DOI: 10.1038/71667
15. Park SH, Kim DS, Kim WG, et al. Terrein: a new melanogenesis inhibitor and its mechanism. Cell Mol Life Sci 2004; 61: 2878-2885. DOI: 10.007/s00018-004-4341-3
16. Kim DS, Cho HJ, Lee HK, et al. Terrein, a fungal metabolite, inhibits the epidermal proliferation of skin equivalents. J Dermatol Sci 2007; 46: 65-68. DOI: 10.1016/j.jdermsci.2006.11.011
17. Lee JC, Yu MK, Lee R, et al. Terrein redices pulpal inflammation in human dental pulp cells. J Endod 2008; 34: 433-437. DOI: 10.1016/j.joen.2008.01.015
18. Lee S, Kim WG, Kim E, et al. Synthesis and melanin biosynthesis inhibitor activity of (+/-)-terrein produced by Penicillium sp. 20135. Bioorg Med Chem Lett 2005; 15: 471-473. DOI: 10.1016/j.bmcl.2004.10.057
19. Raistrick H, Smith G. Studied in the biochemistry of micro-organisms: the metabolic products of Aspergillus terreus Thom. A new mould metabolic product-terrein. Biochem J 1935; 29: 606-611.
20. Bax BE, Alam AS, Banerji B, et al. Stimulation of osteoclastic bone resorption by hydrogen peroxide. Biochem Biophys Res Commun 1992; 183: 1153-1158. DOI: 10.1016/S0006-291X(05)80311-0
21. Fini M, Giavaresi G, Torricelli P, et al. Osteoporosis and biomaterial osteointegration. Biomed Pharmacother 2004; 58: 487-493. DOI: 10.1016/j.biopha.2004.08.016
22. Tengvall P, Lundström I, Sjöqvist L, et al. Titanium-hydrogen peroxide interaction: model studies of the influence of the inflammatory response on titanium implants. Biomaterials 1989; 10: 166-175.
23. Lee MC, Yoshino F, Shoji H, et al. Characterization by electron spin resonance spectroscopy of reactive oxygen species generated by titanium dioxide and hydrogen peroxide. J Dent Res 2005; 84: 178-182. DOI: 10.1177/ 154405910508400213
24. Waddington RJ, Moseley R, Embery G. Reactive oxygen species: a potential role in the pathogenesis of periodontal diseases. Oral Dis 2000; 6: 138-151.
25. Cai H. Hydrogen peroxide regulation of endothelial function: origins, mechanisms, and consequences. Cardiovasc Res 2005; 68: 26-36. DOI: 10.1016/j.cardiores.2005.06.021
26. Fridovich I. Superoxide radical and superoxide dismutases. Annu Rev Biochem 1995; 64: 97-112. DOI: 10.1146/annurev.bi.64.070195.000525
27. Van Remmen H, Ikeno Y, Hamilton M, et al. Life-long reduction in MnSOD activity results in increased DNA damage and higher incidence of cancer but does not accelerate aging. Physiol Genomics 2003; 16: 29-37.
28. Ozmen I, Naziroglu M, Okutan R. Comparative study of antioxidant enzymes in tissues surrounding implant in rabbits. Cell Biochem Funct 2006; 24: 275-281. DOI: 10.1027/cbf.1225
29. Davies KJ. Protein damage and degradation by oxygen radicals. I. General aspects. J Biol Chem 1987; 262: 9895-9901.
30. Halliwell B. The role of oxygen radicals in human disease, with particular reference to the vascular system. Haemostasis 1993; 23(1): 118-126.
31. Tsai CC, Chen HS, Chen SL, et al. Lipid peroxidation: a possible role in the induction and progression of chronic periodontitis. J Periodontal Res 2005; 40: 378-384. DOI: 10.1111/j.1600-0765.2005.00818.x
32. Sinha RK, Tuan RS. Regulation of human osteoblast integrin expression by orthopedic implant materials. Bone 1996; 18: 451-457. DOI: 10.1016/8756-3282(96)00044-0
33. Hata K, Kazunori I, Wada M, et al. Osteoblast response to titanium regulates transcriptional activity of Runx2 through MAPK pathway. J Biomed Mater Res A 2007; 81: 446-452. DOI: 10.1002/jbm.a.31086
34. Chen RM, Chen TL, Chiu WT. Molecular mechanism of nitric oxide-induces osteoblast apoptosis. J Orthop Res 2005; 23: 462-468. DOI: 10.1016/j.orthres.2004.08.011
35. Armour KE, Van't Hof, RJ, Grabowski PS. et al. Evidence for a pathogenic role of nitric oxide in inflammation induced osteoporosis. J Bone Miner Res 1999; 14: 2137-2142. DOI: 10.1359/jbmr.1999.14.12.2137
36. Gronthos S, Zannettino AC, Graves SE, et al. Differential cell surface expression of the STRO-1 and alkaline phosphatase antigens on discrete developmental stages in primary cultures of human bone cells. J Bone Miner Res 1999; 14: 47-56. DOI: 10.1359/jbmr.1999.14.1.47
37. Barker TH, Baneyx G, Cardó-Vila M, et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J Biol Chem 2005; 280: 36483-36493. DOI: 10.1074/jbc.M504663200
38. Nascimento MM, Suliman ME, Silva M, et al. Effect of oral N-acetylcysteine treatment on plasma inflammatory and oxidative stress markers in peritoneal dialysis patients: a placebo-controlled study. Ann Clin Lab Sci 2000; 30: 145-158. DOI: 10.1359/jbmr.1999.14.1.47